Boston Scientific Announces 400th Patient Enrolled in Study of Next-Generation TAXUS® Liberte™ Coronary Stent System
and Paris, France (May 26, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has enrolled its 400th patient in the world